ACE and exocrine pancreatic insufficiency: Interestingly, patients taking angiotensin-converting enzyme (ACE) inhibitors experience pancreatic exocrine insufficiency less frequently [137], presumably due to the potential anti-fibrotic effects of the ACE inhibitors [138].